×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Why Is Emergent BioSolutions (EBS) Stock Up 57% Today?
InvestorPlace
Emergent BioSolutions stock is up on Thursday after the life sciences company posted a surprising profit and strong earnings in Q1 2024.
9 hours ago
Why this Gaithersburg biotech's stock is surging
The Business Journals
When you use an ad blocker and are not logged in as a paid subscriber, we no longer generate the revenue we rely on to bring you exclusive...
3 hours ago
Emergent cuts 300 jobs and shuts down two facilities in cost-cutting drive
Pharmaceutical Technology
The operational changes are expected to save the biotech and manufacturing organisation $80m annually.
6 hours ago
Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start with Significant ...
GuruFocus
Total Revenue: $300 million, up 83% year-over-year.Adjusted Gross Margin: 51%, significantly improved from 5% the previous year.
12 hours ago
Boehringer, Neurocrine Win New Approvals for Humira Biosimilar, Huntington’s Drug
BioSpace
In 2023, the FDA greenlit 55 new drugs and 34 cell and gene therapies. Follow along as BioSpace keeps you up to date on all of the FDA's...
7 hours ago
Emergent BioSolutions Enters Forbearance Agreement - WSJ
WSJ
The forbearance period would stretch to at the latest April 30.
1 month ago
Emergent unveils sweeping plan to reshape its business
Fierce Pharma
Big changes are brewing at Emergent BioSolutions, as the beleaguered contract manufacturer puts its CDMO business on the back burner in a...
8 months ago
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript
The Motley Fool
Emergent is providing critical products to address global health crisis in an increasingly dangerous world. I'm confident that these important...
1 month ago
Emergent Biosolutions (EBS) Reports Q3 Loss, Tops Revenue Estimates
Yahoo Finance
Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -1100% and 5.94%, respectively, for the quarter ended September 2023...
4 months ago
Emergent Bio Investor Suit Advances Over Covid Vaccine Readiness
Bloomberg Law News
Emergent BioSolutions Inc. shareholders can proceed in part with a lawsuit over sharp stock declines following news of contaminated Covid-19...
7 months ago